Treatment of platelet concentrates with the mirasol pathogen inactivation system modulates platelet oxidative stress and NF-κB activation

Transfusion Medicine and Hemotherapy

Volumn 42, Issue 3, 2015, Pages 167-173

  Johnson, Lacey ^a   Marks, Denese ^a  

^a Australian Red Cross Lifeblood   (Australia)

Author keywords

Pathogen inactivation; Platelet; Platelet additive solution; Reactive oxygen species; Riboflavin; Ultraviolet light

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; CARBONYL DERIVATIVE; I KAPPA B ALPHA; NITRITE; PEROXYNITRITE; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; THROMBOCYTE CONCENTRATE; TRANSCRIPTION FACTOR RELA;

ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD SAMPLING; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PATHOGEN REDUCTION SYSTEM; PROTEIN CARBONYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE PRESERVATION;

EID: 84931067849     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000403245     Document Type: Article

References (49)

1. Marschner S, Goodrich R: Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother 2011;38:8-18.
2. Ostrowski SR, Bochsen L, Salado-Jimena JA, Ullum H, Reynaerts I, Goodrich RP, Johansson PI: In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion 2010;50:2210-2219.
3. Picker SM, Steisel A, Gathof BS: Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. Transfusion 2008;48: 1685-1692.
4. ®) treated single-donor platelets resuspended in a mixture of au-tologous plasma and pas. Vox Sang 2009;97:234-239.
5. Johnson L, Winter KM, Reid S, Hartkopf-Theis T, Marschner S, Goodrich RP, Marks DC: The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover. Vox Sang 2011;101:208-214.
6. ® pathogen reduction technology system. Transfus Med Hemother 2013;40:44-48.
7. Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV: Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment. Transfusion 2013;53: 3164-73.
8. Reid S, Johnson L, Woodland N, Marks DC: Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling. Transfusion 2012;52:2094-2103.
9. Schubert P, Culibrk B, Coupland D, Scammell K, Gyongyossy-Issa M, Devine DV: Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein ser-239 phosphorylation in platelet concentrates during storage. Transfusion 2012; 52:397-408.
10. Chen Z, Schubert P, Culibrk B, Devine DV: P38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment. Transfusion 2014; doi: 10.1111/trf.12905.
11. Lee EJ, Jeon MS, Kim BD, Kim JH, Kwon YG, Lee H, Lee YS, Yang JH, Kim TY: Capsiate inhibits ultraviolet B-induced skin inflammation by inhibiting SRC family kinases and epidermal growth factor receptor signaling. Free Radic Biol Med 2010;48:1133-1143.
12. Montana MP, Massad WA, Criado S, Biasutti A, Garcia NA: Stability of flavonoids in the presence of ribo-flavin-photogenerated reactive oxygen species: a kinetic and mechanistic study on quercetin, morin and rutin. Photochem Photobiol 2010;86:827-834.
13. Bouillaguet S, Owen B, Wataha JC, Campo MA, Lange N, Schrenzel J: Intracellular reactive oxygen species in monocytes generated by photosensitive chromophores activated with blue light. Dent Mater 2008;24:1070-1076.
14. Kumar V, Lockerbie O, Keil S, Ruane P, Platz M, Martin C, Ravanat J, Cadet J, Goodrich R: Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photo-chem Photobiol 2004;80:15-21.
15. Feys HB, Van Aelst B, Devreese K, Devloo R, Coene J, Vandekerckhove P, Compernolle V: Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion. Vox Sang 2014;106:307-315.
16. Wachowicz B, Olas B, Zbikowska HM, Buczyński A: Generation of reactive oxygen species in blood platelets. Platelets 2002;13:175-182.
17. Pignatelli P, Pulcinelli FM, Lenti L, Paolo Gazzaniga P, Violi F: Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 1998;91:484-490.
18. Salvemini D, de Nucci G, Sneddon JM, Vane JR: Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol 1989;97:1145-1150.
19. Bakdash N, Williams MS: Spatially distinct production of reactive oxygen species regulates platelet activation. Free Radic Biol Med 2008;45:158-166.
20. Schlenke P: Pathogen inactivation technologies for cellular blood components: an update. Transfus Med Hemother 2014;41:309-325.
21. Rakesh KS, Jagadish S, Vinayaka AC, Hemshekhar M, Paul M, Thushara RM, Sundaram MS, Swaroop TR, Mohan CD, Basappa, Sadashiva MP, Kemparaju K, Girish KS, Rangappa KS: A new ibuprofen derivative inhibits platelet aggregation and ROS mediated platelet apoptosis. PLoS One 2014;9:e107182.
22. Thushara RM, Hemshekhar M, Santhosh MS, Jnanesh-wari S, Nayaka SC, Naveen S, Kemparaju K, Girish KS: Crocin, a dietary additive protects platelets from oxi-dative stress-induced apoptosis and inhibits platelet aggregation. Mol Cell Biochem 2013;373:73-83.
23. Bender K, Göttlicher M, Whiteside S, Rahmsdorf HJ, Herrlich P: Sequential DNA damage-independent and-dependent activation of NF-κB by UV. EMBO J 1998; 17:5170-5181.
24. Chen AC-H, Arany PR, Huang Y-Y, Tomkinson EM, Sharma SK, Kharkwal GB, Saleem T, Mooney D, Yull FE, Blackwell TS, Hamblin MR: Low-level laser therapy activates NF-κB via generation of reactive oxygen species in mouse embryonic fibroblasts. PLoS One 2011;6:e22453.
25. Liu J, Yang D, Minemoto Y, Leitges M, Rosner MR, Lin A: NF-κB is required for UV-induced JNK activation via induction of PKCδ. Mol Cell 2006;21:467-480.
26. O'Dea EL, Kearns JD, Hoffmann A: UV as an amplifier rather than inducer of NF-κB activity. Mol Cell 2008; 30:632-641.
27. Johnson L, Loh YS, Kwok M, Marks DC: In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the Intercept blood system. Transfus Med 2013;23:121-129.
28. Johnson L, Winter KM, Hartkopf-Theis T, Reid S, Kwok M, Marks DC: Evaluation of the automated collection and extended storage of apheresis platelets in additive solution. Transfusion 2012;52:503-509.
29. Skripchenko A, Myrup A, Thompson-Montgomery D, Awatefe H, Moroff G, Wagner SJ: Periods without agitation diminish platelet mitochondrial function during storage. Transfusion 2010;50:390-399.
30. Olas B, Wachowicz B: Role of reactive nitrogen species in blood platelet functions. Platelets 2007;18:555-565.
31. Pacher P, Beckman JS, Liaudet L: Nitric oxide and per-oxynitrite in health and disease. Physiol Rev 2007;87: 315-424.
32. Selley ML, Bartlett MR, Czeti AL, Ardlie NG: The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron. Atherosclerosis 1998; 140:105-112.
33. Kilkson H, Holme S, Murphy S: Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood 1984;64:406-414.
34. 3. Arterioscler Thromb Vasc Biol 1998;18:1698-1706.
35. Praticò D, Iuliano L, Ghiselli A, Alessandri C, Violi F: Hydrogen peroxide as trigger of platelet aggregation. Haemostasis 1991;21:169-174.
36. Naseem KM, Chirico S, Mohammadi B, Bruckdorfer KR: The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation. Biochem J 1996;318:759-766.
37. Kim SH, Lim KM, Noh JY, Kim K, Kang S, Chang YK, Shin S, Chung JH: Doxorubicin-induced platelet procoagulant activities: an important clue for chemotherapy-associated thrombosis. Toxicol Sci 2011;124:215-224.
38. Sabetkar M, Low SY, Bradley NJ, Jacobs M, Naseem KM, Richard Bruckdorfer K: The nitration of platelet vasodilator stimulated phosphoprotein following exposure to low concentrations of hydrogen peroxide. Platelets 2008;19:282-292.
39. Ostrowski SR, Bochsen L, Windeløv NA, Salado-Ji-mena JA, Reynaerts I, Goodrich RP, Johansson PI: He-mostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion 2011;51:344-356.
40. Picker SM, Tauszig ME, Gathof BS: Cell quality of apheresis-derived platelets treated with riboflavin-ul-traviolet light after resuspension in platelet additive solution. Transfusion 2012;52:510-516.
41. Alexandru N, Constantin A, Popov D: Carbonylation of platelet proteins occurs as consequence of oxidative stress and thrombin activation, and is stimulated by ageing and type 2 diabetes. Clin Chem Lab Med 2008; 46:528-536.
42. Prudent M, Sonego G, Abonnenc M, Tissot JD, Lion N: LC-MS/MS analysis and comparison of oxidative damages on peptides induced by pathogen reduction technologies for platelets. J Am Soc Mass Spectrom 2014;25:651-661.
43. Arenas A, Vasquez R, Lopez-Alarcon C, Lissi E, Silva E: Oxidative damage of lysozyme and human serum albumin and their mixtures: a comparison of photosensitized and peroxyl radical promoted processes. Protein J 2011;30:359-365.
44. Silva E, Salim-Hanna M, Edwards A, Becker M, De Ioannes A: A light-induced tryptophan-riboflavin binding: biological implications. Adv Exp Med Biol 1991;289:33-48.
45. Yi D, Ingelse BA, Duncan MW, Smythe GA: Quantification of 3-nitrotyrosine in biological tissues and fluids: generating valid results by eliminating artifactual formation. J Am Soc Mass Spectrom 2000;11:578-586.
46. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991;10:2247-2258.
47. Liu F, Morris S, Epps J, Carroll R: Demonstration of an activation regulated NF-κB/I-κBα complex in human platelets. Thromb Res 2002;106:199-203.
48. Malaver E, Romaniuk MA, D'Atri LP, Pozner RG, Ne-grotto S, Benzadon R, Schattner M. NF-κB inhibitors impair platelet activation responses. J Thromb Hae-most 2009;7:1333-1343.
49. Gambaryan S, Kobsar A, Rukoyatkina N, Herterich S, Geiger J, Smolenski A, Lohmann SM, Walter U: Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase a from an NFκB-IκB complex. J Biol Chem 2010;285:18352-18363.